Mozambique vs Tuvalu: Treatment coverage for lymphatic filariasis
Mozambique
58.3%
in 2024
Tuvalu
65.2%
in 2022
Mozambique rank
38th
Tuvalu rank
35th
Treatment coverage for lymphatic filariasis over time
- Mozambique
- Tuvalu
How they compare
Tuvalu currently reports 65.2% against 58.3% in Mozambique, a difference of 6.9%.
That makes Tuvalu's figure about 1.1 times Mozambique's.
The two have swapped places 7 times across 13 shared years of data; in 2009 it was Mozambique ahead.
Mozambique ranks 38th and Tuvalu ranks 35th of 66 countries.
Mozambique has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.3% | 0.0% | 10.3% | Mozambique |
| 2010s | 52.8% | 27.5% | 25.3% | Mozambique |
| 2020s | 26.4% | 21.7% | 4.7% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Mozambique or Tuvalu?
- Tuvalu, at 65.2% against 58.3% in Mozambique as of 2022.
- What is the difference in treatment coverage for lymphatic filariasis between Mozambique and Tuvalu?
- 6.9%, with Tuvalu ahead.
- How many years of comparable data are there for Mozambique and Tuvalu?
- 13 years are reported by both, from 2009 to 2022.
- How do Mozambique and Tuvalu rank globally for treatment coverage for lymphatic filariasis?
- Mozambique ranks 38th and Tuvalu ranks 35th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.